Halozyme, Inc. · 2 weeks ago
Vice President, Intellectual Property Licensing Counsel
San Diego, CA
Full-time
Onsite
Director/Executive
$264K/yr - $387K/yr
10+ years expHalozyme, Inc. is focused on transforming the patient experience through innovative drug delivery solutions. The Vice President, Intellectual Property Licensing Counsel will support the technology licensing business, collaborating with business development teams on licensing deals and providing legal support for strategic initiatives.
BiotechnologyMarketingMedical
Responsibilities
Support team members in maintaining and managing successful relationships in current collaborations, including parties’ contract obligations and communications
Support the strategy of new ENHANZE, MDASE, auto-injector, or other technology licenses or collaborations in partnership with Business Development
Draft non-disclosure, research, license, and other agreements involving the use or ownership of intellectual property
May periodically be asked to perform diligence and support in a variety of potential life science transactions, including mergers and acquisitions, or in-licenses of new technologies
Work with and advise management and business teams on leveraging Halozyme’s current patent portfolio and growth opportunities
Work closely with IP counsel for Halozyme that prosecute and maintain the IP portfolio
Advise technical and business stakeholders internally, and partner with external counsel on licensing, strategy, and potential IP or licensing litigation
Support the General Counsel and Associate General Counsels in the execution of other strategies and tactics required to achieve Halozyme business goals, as needed
Manage outside counsel engagement on an as-needed basis for certain transactions
Development and delivery of training for business teams on relevant legal topics, including licensing, intellectual property, confidentiality and legal privilege
Interface as needed with other functions and business teams including, business development, product development, manufacturing, compliance, regulatory and finance
Collaborate with current partners, potential partners, law firms, and others as needed
Qualification
Required
J.D. degree or LL.M. degree from an ABA accredited law school, and admission to practice law in a jurisdiction in the U.S
10+ years experience in a law firm and/or in-house licensing of IP, with at least 5 years law firm experience and 4+ years in the biotechnology or pharmaceutical industry (equivalent combination of education/experience may be considered)
Proven strategic transactions leadership experience; experience negotiating and drafting complex licensing and partnering agreements
Life sciences intellectual property law experience required
Excellent analytical and contract drafting skills
Strong written and verbal communication, as well as requisite interpersonal skills to work in a highly functioning, collaborative environment
Demonstrated ability to develop and implement strategic solutions
Preferred
In-house biotechnology experience favorable
Benefits
Full and comprehensive benefit program, including an Employee Stock Purchase Program and 401(k) matching.
Opportunities to grow in a culture that prioritizes learning, development and progression through in-house programs and tuition reimbursement.
Company
Halozyme, Inc.
Halozyme is a biopharmaceutical company bringing disruptive solutions to significantly improve patient experiences and outcomes for emerging and established therapies.
201-500 employees
H1B Sponsorship
Halozyme, Inc. has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2024 (2)
2023 (2)
2022 (3)
2021 (1)
Funding
Current Stage
Public CompanyTotal Funding
$2.75BKey Investors
Janssen Biotechargenx
2025-11-06Post Ipo Debt· $1.3B
2022-08-15Post Ipo Debt· $500M
2021-02-24Post Ipo Debt· $700M
Leadership Team
Helen Torley
President and Chief Executive Officer
Cortney Caudill
Chief Operating Officer
Recent News
GlobeNewswire
2026-01-12
Longevity.Technology
2026-01-07
Company data provided by crunchbase